Objectives: To estimate Australian health-care costs in the year of first occurrence and subsequent years for major diabetes-related complications using administrative health-care data. Methods: The costs were estimated using administrative information on hospital services and primary health-care services financed through Australia's national health insurance system Medicare. Data were available for 70,340 patients with diabetes in Western Australia (mean duration of 4.5 years of follow-up). Multiple regression analysis was used to estimate inpatient and primary care costs. Results: For a man aged 60 years, the average costs in the year the event first occurred were: amputation $20,416 (95% CI 18,670-22,411); nonfatal myocardial infarction ...
Diabetes Mellitus is estimated to affect around one million Australians, a number that is likely to ...
Aims: To estimate the cost of diabetes complications in the United States (U.S.). Methods: We constr...
Aims: Robust cost estimates are required to inform economic analysis of diabetes treatments. We esti...
Objectives: To estimate the incidence of disease and annual disease-specific hospital costs for peop...
Aims: To assess and compare costs associated with diabetes and lesser degrees of glucose intolerance...
Objective: To estimate medical costs associated with 17 major diabetes-related complications and ...
Aim: To develop models to estimate the direct medical costs associated with diabetes-related complic...
Background and aims: To estimate short- and long-term costs of inpatient hospitalization in Sweden f...
AIMS: To develop a model for estimating the immediate and long-term healthcare costs associated with...
Abstract Background Type 2 diabetes is rapidly growing as a proportion of the disease burden in Aust...
Aims: To estimate medical costs associated with 17 diabetes complications and treatment procedure...
Aims To quantify the incremental direct medical costs in people with diabetes...
The cost of diabetes to the health care system is significant and has been well documented. Less wel...
BACKGROUND: Diabetes mellitus in hospital inpatients is most commonly present as a comorbidity rathe...
Objectives: To estimate the incidence-based, lifetime costs of health care and productivity losses a...
Diabetes Mellitus is estimated to affect around one million Australians, a number that is likely to ...
Aims: To estimate the cost of diabetes complications in the United States (U.S.). Methods: We constr...
Aims: Robust cost estimates are required to inform economic analysis of diabetes treatments. We esti...
Objectives: To estimate the incidence of disease and annual disease-specific hospital costs for peop...
Aims: To assess and compare costs associated with diabetes and lesser degrees of glucose intolerance...
Objective: To estimate medical costs associated with 17 major diabetes-related complications and ...
Aim: To develop models to estimate the direct medical costs associated with diabetes-related complic...
Background and aims: To estimate short- and long-term costs of inpatient hospitalization in Sweden f...
AIMS: To develop a model for estimating the immediate and long-term healthcare costs associated with...
Abstract Background Type 2 diabetes is rapidly growing as a proportion of the disease burden in Aust...
Aims: To estimate medical costs associated with 17 diabetes complications and treatment procedure...
Aims To quantify the incremental direct medical costs in people with diabetes...
The cost of diabetes to the health care system is significant and has been well documented. Less wel...
BACKGROUND: Diabetes mellitus in hospital inpatients is most commonly present as a comorbidity rathe...
Objectives: To estimate the incidence-based, lifetime costs of health care and productivity losses a...
Diabetes Mellitus is estimated to affect around one million Australians, a number that is likely to ...
Aims: To estimate the cost of diabetes complications in the United States (U.S.). Methods: We constr...
Aims: Robust cost estimates are required to inform economic analysis of diabetes treatments. We esti...